Literature DB >> 11844973

Bronchiolitis obliterans in a case of juvenile rheumatoid arthritis presented with pneumomediastinum.

Oner Dikensoy1, Nazan Bayram, Ayfer Bingol, Ayten Filiz.   

Abstract

We present a case of bronchiolitis obliterans associated with juvenile rheumatoid arthritis in whom pneumomediastinum was the presenting manifestation. Diagnosis of bronchiolitis obliterans was made on the basis of the clinical history, pulmonary function tests and high-resolution computerized tomography scan findings. Pneumomediastinum resolved in a few days following high-dose nasal oxygen. This case shows that bronchiolitis obliterans can occur in patients with juvenile rheumatoid arthritis. Complicating pneumomediastinum in such cases should be considered as an indication of underlying bronchiolitis obliterans. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11844973     DOI: 10.1159/000049380

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  4 in total

1.  Juvenile rheumatoid arthritis and bronchiolitis obliterans organized pneumonia.

Authors:  Debora Ingrid Sohn; Hugo Armando Laborde; Marta Bellotti; Luis Seijo
Journal:  Clin Rheumatol       Date:  2005-12-15       Impact factor: 2.980

2.  Overlapping juvenile idiopathic arthritis and systemic lupus erythematosus: a case report.

Authors:  Anna Bazsó; Krisztina Sevcic; Ilonka Orbán; Gyula Poór; Zsolt Balogh; Emese Kiss
Journal:  Rheumatol Int       Date:  2010-07-30       Impact factor: 2.631

3.  Importance of Reading and Publishing Case Reports.

Authors:  Öner Dikensoy
Journal:  Turk Thorac J       Date:  2019-10-01

Review 4.  Parenchymal lung involvement in adult-onset Still disease: A STROBE-compliant case series and literature review.

Authors:  Mathieu Gerfaud-Valentin; Vincent Cottin; Yvan Jamilloux; Arnaud Hot; Agathe Gaillard-Coadon; Isabelle Durieu; Christiane Broussolle; Jean Iwaz; Pascal Sève
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.